about
APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrateProx-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemiaIncreased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation.Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension.Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway.Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway InhibitionImproving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy.Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids.Tissue-specific DNA methylation profiles regulate liver-specific expression of the APOA1/C3/A4/A5 cluster and can be manipulated with demethylating agents on intestinal cells.Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene.Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk.Two novel single nucleotide polymorphisms in the promoter of the cellular retinoic acid binding protein II gene (CRABP-II).FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants.Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients.Association between lipid genetic and immunological status in chronically HIV-infected patientsCorrection: FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway.Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers.Fatty acids modulate the effect of darglitazone on macrophage CD36 expression.Cytotoxic effects of the lipid peroxidation product 2,4-decadienal in vascular smooth muscle cells.Aldehydes mediate tissue factor induction: a possible mechanism linking lipid peroxidation to thrombotic events.Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids.Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.Unravelling and Quantifying the "NMR-Invisible" Metabolites Interacting with Human Serum Albumin by Binding Competition and T2 Relaxation-Based Decomposition Analysis.APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis.Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease.Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.Renal and hepatic effects following neonatal exposure to low doses of Bisphenol-A and 137 CsCharacterization of H NMR Plasma Glycoproteins as a New Strategy To Identify Inflammatory Patterns in Rheumatoid ArthritisLetter to Editor: Increased Presence of Remnant Lipoprotein Cholesterol in The Hdl of Diabetic SubjectsEpigenética en la arteriosclerosisPolymorphisms in LPL, CETP, and HL Protect HIV-Infected Patients from Atherogenic Dyslipidemia in an Allele-Dose-Dependent MannerBody mass index correlates with atherogenic lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy menCorrespondenceAssessment of arterial stiffness variables in patients with rheumatoid arthritis: A mediation analysisA variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemiaLow plasma vitamin A concentrations in familial combined hyperlipidemiaVitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia
P50
Q28235497-E871B760-C74D-4B0D-8650-A13E01E12309Q28240059-39EB3F5A-D482-449F-A080-E58F2BB4B76FQ33293923-38FBF0FB-0125-4A87-B449-580E07BD2BF6Q34389210-2B3AFE72-3F80-477B-81C7-01679E54EF6AQ34475040-CDBBC962-6449-45F4-AFE6-29CF4D4B1D1AQ35060802-C140646C-393D-46CA-901E-CF764B6BB32CQ35711172-BF4C3548-6DBD-4274-9362-4F798D7DA4B9Q35759248-F03C7AB1-F4DE-4D74-B69C-7F2EC661C2A0Q37222447-E50C7C93-ED8D-4EE5-9326-BD14ED13D2A7Q38933244-7927AB50-C258-4493-B7D0-02759E28E008Q38985197-2CB84598-92E1-4B50-AE10-BBFE2BF380F0Q40052884-860E5683-21CF-4CDE-BF3E-6BB81303F730Q40601129-AAE45D74-4344-4937-A89F-70821DB5FC21Q40769629-1E4DB339-EF4E-44BD-9C3F-E4703DDC4E69Q41603020-A0C87763-D722-4AD5-A57F-A881B5F24EFBQ41663829-ADD75449-20C9-4195-A47C-9EE0B24806F7Q43105252-88DC41CB-3B54-422B-96F5-9884AC26B886Q44204452-2BE97AEC-B6BA-42A6-BF0B-21BDA0403A5FQ44471149-9247ED20-3455-447C-8240-E49B283A8C74Q44551839-15060398-056D-40CC-84E3-152F38769B04Q44645997-AD976075-AF15-488C-86A6-A3B04A982655Q46011608-D2100BA3-32AA-462B-A8EF-6E2C0127F3ACQ47739407-AEDD9F4B-7C85-46DD-8D75-BDC2CD58AFBBQ48359596-39EDD6F5-E528-45D7-8F30-17119B58DE9BQ49055752-B4006796-2308-4767-82A5-3020C3DF7E25Q49341653-F129380D-5D60-41AD-A538-E3361CD93FB5Q51473734-0DE6559D-A02D-4227-A976-BC6F74AE5DC5Q53827279-CD276491-0B42-4444-95BE-A640990DFE87Q54524130-1E914F96-D1C8-49D8-B62D-816DD9A90D01Q57266400-6C747326-9A36-4B79-9E0E-FADBF7C31E9EQ57792873-B4996C91-9C8F-450C-A7C8-D37BEDB24DFDQ61409362-CAFF84FF-51AC-4176-BDB1-1520D36B7B79Q61409363-5A8BFE2C-4029-47D3-89DA-622F9EEDAC90Q61409364-459022AC-6892-4B05-92D6-1D90F4A5E892Q61409366-66922B24-9E88-40DE-BDAD-90B922925442Q61945535-83B409EE-8108-4AE5-BD78-8F74F0C954B4Q64095832-E44721A5-A4A3-495D-8467-A9D382AB0311Q73494105-BAB27593-1283-48AD-8897-FF8D6779284BQ74078691-3947B56B-6119-45CC-8564-A411894C0BF7Q74579990-A4CF3C05-6794-4356-B3C2-B0684960C4EC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joan-Carles Vallvé
@ast
Joan-Carles Vallvé
@en
Joan-Carles Vallvé
@es
Joan-Carles Vallvé
@nl
Joan-Carles Vallvé
@sl
type
label
Joan-Carles Vallvé
@ast
Joan-Carles Vallvé
@en
Joan-Carles Vallvé
@es
Joan-Carles Vallvé
@nl
Joan-Carles Vallvé
@sl
prefLabel
Joan-Carles Vallvé
@ast
Joan-Carles Vallvé
@en
Joan-Carles Vallvé
@es
Joan-Carles Vallvé
@nl
Joan-Carles Vallvé
@sl
P106
P31
P496
0000-0001-8711-9618